Special Routine Chemistry And Laboratory Reagents Procuremen Tender Notice

Description

Re-tender for Pathology and Blood Bank demand 2026-27, including special and routine chemistry analyzers on reagent rental basis and reagents, consumables and laboratory kits. The successful bidder must provide three special chemistry analyzers and two routine chemistry analyzers, comprising two special chemistry analyzers for the laboratory and one for the blood bank. The special and routine chemistry integrated analyzers must be FDA or CE marked and supplied with controls, calibrators, consumables, external quality assurance programme, tips, cuvettes, wash and cleaning solutions and maintenance, with necessary interface to LIS/HMS. The successful bidder will be responsible for repair and maintenance of all analyzers, RO plant and air conditioning. Special and routine chemistry framework contract will initially be for one year and may be extended for up to three years subject to satisfactory performance and approval of the Board of Management or Administration Committee. The successful bidder must also provide RO plant, UPS and cooling system for relevant equipment at its own cost, including services and maintenance. The lowest bidder will be determined on the overall package price for special and routine chemistry, and downtime penalty will apply under the rules. Chemistry test demand includes Troponin I Ultra Sensitive by CLIA, 65,000 tests; Anti-HCV by CLIA/ELISA for laboratory and blood bank, 40,000 tests; HBsAg by CLIA/ELISA, 40,000 tests; HIV by CLIA/ELISA, 40,000 tests; VDRL by CLIA/ELISA for blood bank, 10,000 tests; T3 by CLIA, 8,000 tests; T4 by CLIA, 8,000 tests; TSH by CLIA, 11,000 tests; Ferritin by CLIA, 2,000 tests; Pro BNP by CLIA, 1,000 tests; glucose, urea and creatinine by end point or kinetic method, 65,000, 85,000 and 85,000 tests respectively; inorganic phosphorus, 6,000 tests; uric acid, 12,000 tests; calcium, 12,000 tests; magnesium, 13,000 tests; total bilirubin, 22,000 tests; direct bilirubin, 22,000 tests; alkaline phosphatase, 22,000 tests; ALT, 25,000 tests; CPK, 40,000 tests; CK-MB, 50,000 tests; AST, 10,000 tests; LDH, 10,000 tests; cholesterol, 18,000 tests; triglyceride, 16,000 tests; HDL direct, 16,000 tests; LDL direct, 16,000 tests; total protein, 1,500 tests as stated in the demand; albumin, 1,000 tests; quantitative RA factor, 1,000 tests; quantitative ASO titre, 5,000 tests; quantitative CRP, 10,000 tests; and serum electrolytes Na, K and Cl, 45,000 tests. The additional demand for reagents and laboratory supplies includes an HbA1c HPLC analyzer, FDA or CE marked, with daily controls, calibrators, consumables, ISO 17043-accredited external quality assurance and inter-laboratory comparison programmes, LIS/HMS interface and maintenance, 20,000 tests; Alfa Diluent for Swelab-Boule, 15 packs; Alfa Lyse for Swelab-Boule, 15 packs; VDRL syphilis devices for blood bank, 2,000; 24G butterfly needles, 2,000; yellow tips, 60 packs of 500 pieces; glass slides, 500 packs of 72 pieces; diagnostic discs, 10 vials; sensitivity discs, 30 vials; blood agar, 1; MacConkey agar, 1; ZN stain, 1 set; Gram stain, 1 set; Giemsa stain, 2 one-litre units; methanol, 3 units of 2.5 litres; sterile urine containers, 12,000; and reverse grouping gel cards for blood bank, 1,000. The HbA1c HPLC framework contract will initially be for one year and may be extended for three years or more by mutual consent. The total estimated cost stated in the demand is Rs. 245,867,000. The supplied demand extract does not state the bid submission or opening deadline, bid security, or complete procurement procedure for this re-tender; the deadline is therefore recorded using the standard 15-day fallback date. Pro Tip: Medical laboratory suppliers searching for pathology tenders, blood bank reagents, CLIA chemistry analyzers, reagent rental contracts, HbA1c HPLC analyzers, diagnostic kits and laboratory consumables should examine analyzer specifications, reagent compatibility, quality assurance accreditation, LIS/HMS interface, equipment maintenance and framework contract obligations.

General Instructions

---

Organization Contact

---

Tags

medical, laboratory, pharma

Closing Date: 23 Nov 2026